Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.
Single-Use Simplicity under control
ProductsSingle-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.
Protein flags Car-T cells for digestion by NK cells
Latest NewsFlagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report.
Biotalys starts field testing for biofungicide
Latest NewsBelgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program.
Worldwide Clinical Trials wins the CRO Leadership Awards
Sponsored PublicationsGlobal contract research organization honored as top outsourcing partner, earning high marks in several categories from Industry Standard Research.
Calluna Pharma strengthens management
AppointmentsOslo-based Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance.
Three companies launch gene therapy alliance for eye diseases
Latest NewsAI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.
Obesity: reseachers switch on brown fat cells
Latest NewsA German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes.
Reinforcement for Supervisory Board
AppointmentsDr Trevor Hawkins, entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Polish molecular diagnostic company Genomtec S.A.
Klineo raises €2m to speed up access to cancer trials
Latest NewsParis-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.
`
Locate Bio Ltd raises £9.2m venture capital
Latest NewsUniversity Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before.